| Biomarker ID | 1470 |
| PMID | 25065599 |
| Year | 2014 |
| Biomarker | miR-135a |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in GS ≥ 8 |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: DNA-binding transcription factor activity; DNA-binding transcription factor activity, RNA polymerase II-specific; Gene expression (Transcription); synapse; nuclear chromatin |
| Experiment | Glesaon Score ≥ 8 and Gleason Score <8 |
| Type of Biomarker | Prognostic |
| Cohort | 56 tumors and pair-matched adjacent normal tissues from prostatectomy were selected |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.01 |
| Method Used | RT–qPCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |